Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1999;84:157-165

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clemo, H. F.
Right arrow Articles by Baumgarten, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clemo, H. F.
Right arrow Articles by Baumgarten, C. M.
Related Collections
Right arrow Animal models of human disease
Right arrow Arrythmias-basic studies
Right arrow Heart failure - basic studies
(Circulation Research. 1999;84:157-165.)
© 1999 American Heart Association, Inc.


Original Contribution

Swelling-Activated Chloride Current Is Persistently Activated in Ventricular Myocytes From Dogs With Tachycardia-Induced Congestive Heart Failure

Presented previously in abstract form (Biophys J. 1998;74:A325).

Henry F. Clemo, Bruce S. Stambler, Clive M. Baumgarten

From the Departments of Internal Medicine (H.F.C.) and Physiology (H.F.C., C.M.B.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Va, and Division of Cardiology (B.S.S.), Case Western Reserve University, and University Hospitals of Cleveland, Cleveland, Ohio.

Correspondence to Henry F. Clemo, MD, PhD, Department of Physiology, Medical College of Virginia, PO Box 980551, Richmond, VA 23298-0551. E-mail hclemo{at}hsc.vcu.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract—The hypothesis that cellular hypertrophy in congestive heart failure (CHF) modulates mechanosensitive (ie, swelling- or stretch-activated) anion channels was tested. Digital video microscopy and amphotericin-perforated-patch voltage clamp were used to measure cell volume and ion currents in ventricular myocytes isolated from normal dogs and dogs with rapid ventricular pacing-induced CHF. In normal myocytes, osmotic swelling in 0.9T to 0.6T solution (T, relative osmolarity; isosmotic solution, 296 mOsmol/L) was required to elicit ICl,swell, an outwardly rectifying swelling-activated Cl current that reversed near –33 mV and was inhibited by 1 mmol/L 9-anthracene carboxylic acid (9AC), an anion channel blocker. Block of ICl,swell by 9AC simultaneously increased the volume of normal cells in hyposmotic solutions by up to 7%, but 9AC had no effect on volume in isosmotic or hyperosmotic solutions. In contrast, ICl,swell was persistently activated under isosmotic conditions in CHF myocytes, and 9AC increased cell volume by 9%. Osmotic shrinkage in 1.1T to 1.5T solution inhibited both ICl,swell and 9AC-induced cell swelling in CHF cells, whereas osmotic swelling only slightly increased ICl,swell. The current density for fully activated 9AC-sensitive ICl,swell was 40% greater in CHF than normal myocytes. In both groups, 9AC-sensitive current and 9AC-induced cell swelling were proportional with changes in osmolarity and 9AC concentration, and the effects of 9AC on current and volume were blocked by replacing bath Cl with methanesulfonate. CHF thus altered the set point and magnitude of ICl,swell and resulted in its persistent activation. We previously observed analogous regulation of mechanosensitive cation channels in the same CHF model. Mechanosensitive anion and cation channels may contribute to the electrophysiological and contractile derangements in CHF and may be novel targets for therapy.


Key Words: arrhythmia • cardiomyopathy • cardiac edema • cell size • ion channel gating


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Aswelling-activated, outwardly rectifying Cl current has been described in mammalian cardiac myocytes,1 2 3 4 5 including human atrial cells.6 7 This current has been termed ICl,swell. Several molecules have been postulated to function as swelling-activated Cl channels or channel regulators including ClC-2,8 PICln,9 10 P-glycoprotein,11 12 and phospholemman.13 However, more recent evidence favors the idea that ICl,swell in cardiac myocytes is due to activation of ClC-3.14

The significance of ICl,swell for cardiac function under physiological and pathophysiological conditions remains uncertain. On the basis of the magnitude and voltage dependence of the current, activation of ICl,swell is thought to modulate cardiac electrical activity.15 16 In addition, we reported17 that 9-anthracene carboxylic acid (9AC), a blocker of ICl,swell,1 18 increases the volume of intact ventricular myocytes after osmotic swelling when ICl,swell is expected to be activated, but 9AC has no effect on cell volume under isosmotic conditions when the channels underlying ICl,swell are thought to be closed.

Another situation in which ICl,swell may be important is congestive heart failure (CHF). The hemodynamic perturbations responsible for the development of CHF and cellular hypertrophy place myocytes under mechanical stress and lead to complex cellular remodeling19 and activation of multiple intracellular signaling systems.20 Using the perforated-patch voltage clamp method, we recently found that ICir,swell, an inwardly rectifying, Gd3+-sensitive cation current normally detected only after osmotic cell swelling,21 became persistently activated under isosmotic conditions in ventricular myocytes isolated from animals with CHF induced by tachycardia.22 Moreover, block of ICir,swell resulted in significant volume changes in normal rabbit,21 as well as in normal and CHF dog22 myocytes.

In light of the modulation of swelling-activated cation channels by CHF, the present study was designed to determine whether ICl,swell also is transformed in a canine model of CHF produced by several weeks of rapid ventricular pacing. This model has been extensively characterized in both dogs and pigs.23 Chronic tachycardia produces biventricular dilation with eccentric cellular hypertrophy, decreases contractility, downregulates the response to catecholamines, atrial natriuretic peptide, renin, and endothelin-I, and decreases the density of the myocardial collagen network. These characteristics are shared with dilated cardiomyopathy in humans,24 25 26 27 and the model is useful for considering the role of ICl,swell in CHF.

Concurrent perforated-patch voltage clamp and cell-volume determinations revealed that ICl,swell was persistently activated in isosmotic media in ventricular myocytes isolated from dogs with CHF. Osmotic swelling did not significantly increase ICl,swell, and osmotic shrinkage inhibited the current. In contrast, ICl,swell was found in normal canine myocytes only after osmotic swelling. In addition, 9AC induced cell swelling that was proportional to the magnitude ICl,swell blocked in both CHF and normal myocytes. These data are consistent with the idea that elongated hypertrophic myocytes from dogs in CHF behave as if they are swollen. Anion fluxes via ICl,swell may contribute to the sequelae of CHF and may represent a novel target for therapy.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Heart Failure Model
Heart failure was produced as previously described.22 Adult mongrel dogs underwent permanent transvenous pacing of the right-ventricular apex at 235 bpm for 4 to 6 weeks. Ventricular dysfunction was documented using 2-dimensional echocardiography, which showed a significant fall in left-ventricular ejection fraction from 0.65±0.06 to 0.23±0.09 and significant increases in left-ventricular end systolic volume from 19.5±7.9 to 61.4±15.3 mL and in left-ventricular end diastolic volume from 50.3±11.9 to 75.5±13.9 mL.22 Clinical evidence of CHF including anorexia, lethargy, ascites, tachypnea, and/or muscle wasting also was noted.

Cell Isolation
Using a median thoracotomy approach, portions of the left and right ventricle were taken from anesthetized dogs (normal n=4, CHF n=6). After washing in nominally Ca2+-free Tyrode solution equilibrated with 100% O2, the right- and left-ventricular samples were then divided into {approx}1-mm2 pieces with a scalpel and were dispersed in an albumin-containing collagenase-pronase solution described previously.22 28 After filtration to remove incompletely digested material, the isolated cells were washed twice and then stored in a modified Kraft-Brühe solution containing (in mmol/L) 132 KOH, 120 glutamic acid, 2.5 KCl, 10 KH2PO4, 1.8 MgSO4, 0.5 K2EGTA, 11 glucose, 10 taurine, and 10 HEPES (pH 7.2; 295 mOsmol/L). Typical yields were >=50% Ca2+-tolerant, rod-shaped cells. Myocytes were used within 6 hours of harvesting, and only quiescent cells with regular striations and no evidence of membrane blebbing were selected for study.

Experimental Solutions
Cells were placed in a glass-bottomed chamber ({approx}0.3 mL) and were superfused with bathing solution ({approx}22°C) at 3 mL/min; solution changes were complete within 10 s. The standard bathing solution contained (in mmol/L) 65 NaCl, 5 KCl, 2.5 CaSO4, 0.5 MgSO4, 5 HEPES, 10 glucose, and 17 to 283 mannitol (pH 7.4). Solutions were designed to allow adjustment of osmolarity with mannitol at a constant ionic strength. The role of physiological cations and anions was evaluated by replacing Na+ and K+ in the bathing media with equimolar amounts of N-methyl-D-glucamine (NMDG) in some experiments and by replacing Cl in the bathing media with equimolar amounts of methanesulfonate in others. Isosmotic (IT; T, relative osmolarity) solution was set as 296 mOsmol/L. The osmolarity of hyposmotic solutions (0.6T to 0.9T) ranged from 178 to 266 mOsmol/L and was 444 mOsmol/L in hyperosmotic solutions (1.5T). A freezing-point depression osmometer (Osmette S; Precision Systems) was used to routinely verify solution composition.

Voltage Clamp Technique
Patch electrodes with a tip diameter of 3 to 4 µm and a resistance of 0.5 to 1 M{Omega} were made from borosilicate capillary tubing (7740 glass with filament; 1.5 mm OD, 1.12 mm ID). Pipettes usually were filled with solution containing (in mmol/L) 120 potassium aspartate; 10 KCl, 10 NaCl, 3 MgSO4, and 10 HEPES (pH 7.1). For experiments in Na+- and K+-free bathing media, Na+ and K+ salts in the pipette solution were replaced with Cs+ salts, and for experiments in Cl-free bathing media, Cl in the pipette solution was reduced to {approx}5 mmol/L by replacing NaCl and KCl with the corresponding aspartate salts.

The perforated-patch method was used for all studies to avoid unpredictable cell swelling and changes in membrane currents that often slowly occur with the ruptured patch technique.2 21 Amphotericin-B (Sigma Chemical Co) was freshly dissolved in DMSO (Sigma) and then diluted in electrode filling solution to give final amphotericin and DMSO concentrations of 100 µg/mL and 0.2% (vol/vol), respectively. The tip of the pipette was dipped into amphotericin-free solution for 2 s, pipettes were then backfilled with ionophore, and gigaseals were formed as rapidly as possible. Access resistance decreased to 7 to 10 M{Omega} within {approx}20 minutes of seal formation, and then experimental protocols were begun. In all plots of cell volume, time 0 is defined as the time of seal formation. Cell volume remained unchanged as amphotericin inserted into the patch and equilibrium was established across the perforated-patch membrane.

An Axoclamp 200A amplifier (Axon) was used to record whole-cell currents. Voltage clamp protocols, electrophysiological and video data acquisition, and off-line data analysis were controlled by custom programs written in ASYST (Keithley). Slow voltage ramps (28 mV/s) were applied to examine quasi–steady-state currents that may contribute to regulation of cell volume. The voltage was stepped from –80 mV to +40 mV for 20 ms; ramped to –100 mV over 5 s; and, after 10 ms, ramped back to +40 mV over 5 s. Currents elicited by the depolarizing and hyperpolarizing legs of the ramp were virtually identical22 and were averaged to cancel the small capacitative current. Ramp currents were digitized at 1 kHz after low-pass filtering at 200 Hz. Membrane capacitance was calculated from the integral of the current transient in response to 10-mV hyperpolarizing pulses. The bath was grounded via a 3 mol/L KCl agar bridge, and the reported membrane potential (Em) values were corrected for the liquid junction potential between the bath and the pipette.

Determination of Relative Cell Volume
Methods for determining relative cell volume have been described previously.28 29 An inverted microscope (Diaphot; Nikon, Inc) equipped with Hoffman modulation optics (x40; 0.55 numerical aperture) and a high-resolution TV camera (CCD72; Dage-MTI) coupled to a video frame grabber (Targa-M8; Truevision) was used to image myocytes. Images were captured on-line each time a ramp protocol was performed. A combination of commercial (MOCHA; SPSS) and custom (ASYST; Keithley) programs was used to determine cell width, length, and the planar area of the image.

Changes in cell width and thickness on exposure to anisosmotic solutions are proportional.30 Using each cell as its own control, relative cell volume was calculated as follows: volt/volc= (areatxwidtht)/(areacxwidthc), where t and c refer to test (eg, 0.6T) and control (1T) solutions, respectively. The value of relative cell volume is independent of assumptions regarding the geometric shape of the cross section of the myocyte as long as the shape does not change. These methods provide estimates of relative cell volume that are reproducible to <1%.28 29 30

Statistics
Data are reported as mean±SEM, and n represents the number of cells, unless otherwise noted. Mean current densities were expressed in pA/pF to account for differences in cell membrane area. When multiple comparisons were made, ANOVA and Bonferroni's method for group comparisons were used. For simple comparisons, a Student's t test was performed. All statistical analyses were conducted with SigmaStat 2.0 (SPSS).


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Morphological and Electrophysiological Characteristics of Myocytes
Table 1Down summarizes the characteristics of cells selected for study. Myocytes from hearts subjected to rapid ventricular pacing were 17.4% longer than those from normal hearts, whereas cell width was not significantly different. On the basis of morphometric measurements, the estimated cell volume of CHF myocytes was 34.6% greater than that for normal cells. The sarcolemmal surface area of CHF cells also was larger, as evidenced by a 19.2% increase in membrane capacitance. Although these pacing-induced changes in the morphometric and electrophysiologic properties of isolated myocytes are very similar to those reported previously,22 it is uncertain whether they fully represent the in vivo situation. The myocytes studied here are not an unbiased sample of myocardial cells because they were selected as being appropriate for both patch clamp and imaging. In addition, the volume of cells in vitro may not be equal their volume in vivo.


View this table:
[in this window]
[in a new window]
 
Table 1. Morphological and Electrical Parameters of Canine Ventricular Myocytes in Isosmotic Solution

ICl,swell in Normal Canine Ventricular Myocytes
An outwardly rectifying Cl current that is activated by osmotic swelling and blocked by 9AC has been identified in cardiac myocytes and is termed ICl,swell.1 2 3 The effect of osmotic swelling on whole-cell currents in isolated canine ventricular myocytes under perforated-patch conditions is shown in Figure 1ADown. A 5-minute exposure to 0.6T hyposmotic solution containing permeant anions and cations evoked an outwardly rectifying current at potentials positive to –65 mV and an inwardly rectifying current at more negative potentials. Returning to isosmotic solution (1T) completely restored the initial current-voltage (I-V) relationship.



View larger version (10K):
[in this window]
[in a new window]
 
Figure 1. Effect of osmotic swelling on whole-cell currents recorded by amphotericin-perforated-patch method from a normal canine myocyte. A, I-V relationships in isosmotic (1T) and hyposmotic (0.6T) solutions are shown. Traces are average of hyperpolarizing and depolarizing ramps. In bath solution containing Na+, K+, and Cl, osmotic swelling increases both inward and outward currents. B, 9AC (1 mmol/L), a blocker of ICl,swell, markedly attenuated the swelling-activated current in 0.6T solution but had little effect in 1T solution. C, 9AC-sensitive difference currents calculated as current in 9AC-free minus that in 9AC-containing 1T and 0.6T solutions are shown. The swelling-activated 9AC-sensitive current (0.6T) outwardly rectified, reversed at –33 mV, and was denoted ICl,swell.

Cells then were treated with 1 mmol/L 9AC, a blocker of ICl,swell, and the effect of osmotic swelling on membrane current was tested again (Figure 1BUp). 9AC did not affect the I-V relationship in 1T solution, but the Cl channel blocker substantially reduced the outwardly rectifying current evoked by osmotic swelling. 9AC-sensitive difference currents in 1T and 0.6T solutions, calculated as the current in 9AC-free solution minus that in the presence of 1 mmol/L 9AC, are shown Figure 1CUp. During osmotic swelling, 9AC blocks an outwardly rectifying current that reversed near –33 mV. This value is similar to the Cl- equilibrium potential, ECl, of –31.6 mV calculated from bath and pipette solutions. In contrast, 9AC-sensitive current was negligible in 1T solution when swelling- or stretch-activated channels (SACs) were expected to be closed. A swelling-activated, outwardly rectifying, 9AC-sensitive current was seen in 13 of 18 normal cells tested. However, all of the swelling-activated current was not blocked by 9AC. A 9AC-insensitive inwardly rectifying component previously was shown to be a Gd3+-sensitive swelling-activated cation current.21 22

The magnitude of ICl,swell was related to the extent of myocyte swelling. The I-V relationship and relative cell volume were recorded simultaneously in selected hyposmotic (0.6T to 0.9T), isosmotic (1T), and hyperosmotic (1.5T) solutions±1 mmol/L 9AC, and 9AC-sensitive currents at each osmolarity are plotted in Figure 2ADown. 9AC had no effect on the I-V relationship under isosmotic conditions and after cell shrinkage in 1.5T. In contrast, a significant 9AC-sensitive current (–0.25±0.02 pA/pF at –80 mV, P<0.001) was recorded in 0.9T solution after only a modest increase in cell volume (7.0±1.1%, P=0.002), and further swelling increased the 9AC-sensitive current. Nevertheless, the currents in 0.7T and 0.6T solutions were not distinguishable (–0.56±0.04 versus –0.60±0.04 pA/pF at –80 mV, P=0.5; 1.76±0.18 versus 2.06±0.21 pA/pF at +40 mV, P=0.31), although myocyte swelling was significantly greater in 0.6T than 0.7T solution (Figure 2BDown).



View larger version (25K):
[in this window]
[in a new window]
 
Figure 2. Graded 9AC-sensitive current and 9AC-induced cell swelling were observed in normal myocytes after swelling in 0.6T to 0.9T hyposmotic solutions but not in isosmotic (1T) or hyperosmotic (1.5T) solutions. A and B, Average 9AC-sensitive currents (A) and average cell volumes in the absence and presence of 1 mmol/L 9AC (B). As bath osmolarity was decreased, 9AC-sensitive current and 9AC-induced cell swelling increased. Maximum responses were obtained at osmolarities <=0.7T. 9AC-sensitive current reversed at –33.5±0.8 mV after equilibration in 0.6T solution. In this and subsequent figures, time 0 for volume measurements corresponds to sealing of the amphotericin-filled pipette on the cell. Myocyte volume in 1T solution did not change during the 20-minute period of patch perforation. C, 9AC-sensitive current at –80 mV and 9AC-induced cell swelling plotted vs bath relative osmolarity (n=8 cells).

Figure 2BUp also shows that 9AC increased cell volume in hyposmotic solutions coincident with block of the outwardly rectifying swelling-activated current. For example, relative cell volume increased from 1.311±0.014 in 0.6T solution to 1.381±0.013 in 0.6T+9AC (P=0.006). In contrast, 9AC did not alter cell volume in 1T or 1.5T solutions in which 9AC-sensitive currents were not detected. The effects of 9AC on membrane current and cell volume are summarized in Figure 2CUp, in which the 9AC-sensitive current at –80 mV and 9AC-induced cell swelling are plotted against superfusate osmolarity. Both actions of 9AC became apparent and saturated over the same range of osmolarities, 0.9T to 0.6T, and neither cell volume nor membrane current was affected in 1T or 1.5T solutions.

Persistent Activation of 9AC-Sensitive Current in CHF Myocytes
In tachycardia-induced cardiomyopathy, a Gd3+-sensitive, inwardly rectifying cation SAC, ICir,swell, is chronically activated under isosmotic conditions and is inhibited by cell shrinkage in hyperosmotic solution.22 Therefore, we investigated whether the regulation of swelling-activated, 9AC-sensitive current also is remodeled in pacing-induced CHF. To test this possibility, the 9AC-sensitive current and cell volumes of myocytes isolated from CHF dogs were measured simultaneously at osmolarities ranging from 0.6T to 1.5T.

Measurement of the 9AC-sensitive current in a CHF cell is illustrated in Figure 3Down. I-V relationships were recorded in the absence (Figure 3ADown) and presence (Figure 3BDown) of 1 mmol/L 9AC both in 1T solution and after osmotic shrinkage in 1.5T solution, and the 9AC-sensitive difference currents are plotted (Figure 3CDown). A 9AC-sensitive, outwardly rectifying current that reversed at –34 mV was observed under isosmotic conditions (1T) in the CHF cell and was abolished after cell shrinkage in hyperosmotic 1.5T solution. Persistent activation of the 9AC-sensitive current under isosmotic conditions in CHF myocytes sharply contrasts with results from normal cells (compare Figures 2CUp and 3CDown), in which osmotic swelling was required to activate the 9AC-sensitive current.



View larger version (10K):
[in this window]
[in a new window]
 
Figure 3. Effect of osmotic swelling on whole-cell currents in a CHF myocyte bathed in solution containing Na+, K+, and Cl. A and B, Currents under isosmotic (1T) and hyperosmotic (1.5T) conditions in the absence (A) and presence (B) of 1 mmol/L 9AC. Osmotic shrinkage reduced both inward and outward currents. C, 9AC-sensitive difference currents obtained by digitally subtracting the curves in panels A and B. A 9AC-sensitive, inwardly rectifying current was present in CHF cells under isosmotic conditions (1T) and was abolished by osmotic shrinkage (1.5T).

The dependence of the I-V relationship for 9AC-sensitive current on osmotic cell swelling in CHF cells is characterized in Figure 4Down. Graded swelling of cells in hyposmotic solutions (0.9T to 0.6T) did not significantly increase the 9AC-sensitive current at –80 mV from the current observed in 1T solution (Figure 4ADown, P=0.535). Consistent with the observation that ICl,swell was persistently activated, exposure to 9AC caused a cell swelling of 7.6±0.8% under isosmotic conditions in CHF cells, and osmotic swelling did not significantly increase the 9AC-induced cell swelling (Figure 4BDown, P=0.109). The reversal potential (Erev) for the 9AC-sensitive current in CHF myocytes was –33.1±0.7 mV in 1T solution, indistinguishable from that in normal myocytes in 0.6T solution (compare Figures 2AUp and 4ADown). The finding that 9AC-sensitive current and 9AC-induced cell swelling were independent of solution osmolarity is more clearly illustrated in Figure 4CDown, in which the responses to 9AC are plotted as a function of solution osmolarity. 9AC-sensitive effects were seen in 22 of 23 CHF cells under isosmotic conditions (Figures 4Down, 5Down, and 7Down); the 9AC-sensitive current at –80 mV was –0.77±0.05 pA/pF, and 9AC caused a 7.9±0.5% cell swelling.



View larger version (22K):
[in this window]
[in a new window]
 
Figure 4. ICl,swell was chronically activated in isolated CHF myocytes. A and B, Average 9AC-sensitive currents (A) and average cell volumes in the absence and presence of 1 mmol/L 9AC (B) in 1T to 0.6T solutions. In 1T solution, ICl,swell was –0.75±0.06 pA/pF at –80 mV, and 9AC caused a 7.6% increase in cell volume. Further osmotic swelling did not significantly alter the response to 9AC. 9AC-sensitive current reversed at –33.1±0.7 mV in 1T solution. C, 9AC-sensitive current at –80 mV and 9AC-induced cell swelling plotted vs bath relative osmolarity (n=10 cells). Myocyte volume in 1T solution did not change during the 20-minute period of patch perforation.



View larger version (24K):
[in this window]
[in a new window]
 
Figure 5. Osmotic shrinkage abolished ICl,swell in CHF myocytes. A and B, Average 9AC-sensitive currents (A) and average cell volumes in the absence and presence of 1 mmol/L 9AC (B) in 1T to 1.5T solutions. ICl,swell decreased as bath osmolarity was increased. At –80 mV, ICl,swell was not significantly different from 0 in >=1.4T. Osmotic shrinkage also reduced the effect of 9AC on cell volume. C, 9AC-sensitive current at –80 mV and 9AC-induced cell swelling plotted vs bath relative osmolarity (n=6 cells).



View larger version (25K):
[in this window]
[in a new window]
 
Figure 7. Dose dependence of 9AC-sensitive current and 9AC-induced cell shrinkage in normal (n=5) and CHF (n=6) myocytes. Normal cells were osmotically swollen (0.6T) to activate ICl,swell, and CHF cells were studied in isosmotic solution. Cells were exposed to each concentration of 9AC for 5 minutes, a time sufficient to obtain the steady-state response. A and D, Average 9AC-sensitive currents with 0.01 to 1 mmol/L 9AC in normal (A) and CHF (D) myocytes. Times (a through e) of recording of I-V relationships are denoted in B and E. B and E, Concurrent measurements of cell volumes of normal (B) and CHF (E) cells. C and F, comparison of 9AC-sensitive current at –80 mV ({blacksquare}) and 9AC-induced cell swelling () for normal (C) and CHF (F) cells. Stepwise increases in 9AC concentration elicited proportional block of current at –80 mV and cell swelling.

The similarity between the responses of CHF cells to 9AC under isosmotic conditions and that of normal cells after osmotic swelling suggested that CHF myocytes behave as if they are swollen even under isosmotic conditions, as was previously argued to explain the behavior of cation SACs in the same CHF model.22 If this idea is correct, osmotic cell shrinkage would be expected to block the 9AC-sensitive current and 9AC-induced cell swelling in CHF cells. To test this possibility, the response of 9AC in CHF cells in isosmotic solution (1T) was compared with that in hyperosmotic solution (1.1T to 1.5T). Figure 5AUp shows that graded osmotic shrinkage caused a graded reduction in the magnitude of the 9AC-sensitive current, and ICl,swell was undetectable in 1.4T solution. Concurrently with the reduction of ICl,swell, 9AC-induced cell swelling decreased as bathing solution osmolarity was increased (Figure 5BUp). The dependence of the responses to 9AC on solution osmolarity are summarized in Figure 5CUp.

Cell Volume Dependence of 9AC Sensitivity of Normal and CHF Myocytes
The responses of normal and CHF myocytes are directly compared in Figure 6Down, in which the 9AC-sensitive current at –80 mV (Figure 6ADown) and the 9AC-induced cell swelling (Figure 6BDown) are plotted as functions of cell volume before application of 1 mmol/L 9AC in 0.6T to 1.5T solution. CHF cells remained responsive to 9AC even after shrinking to 0.872±0.011 in 1.3T solution, whereas normal cells became sensitive to 9AC only after swelling to 1.071±0.008 in 0.9T solution. The maximum response to 9AC was observed at cell volumes >=1.073±0.011 (<=0.9T) in CHF cells and >=1.254±0.012 (<=0.7T) in normal cells, respectively. Thus, the set point for 9AC sensitivity appeared to be shifted to a relative cell volume {approx}0.18 lower in CHF cells than in normal myocytes. The 9AC-sensitive current and volume changes in Figure 6CDown are plotted as a percentage of the maximal 9AC-induced change. The relationship between block of current and cell swelling was linear over the range of osmolarities explored and suggests a tight coupling of these processes.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 6. 9AC-sensitive current and 9AC-induced cell swelling depend on cell volume. Data were taken from Figure 2Up (normal cells, {blacksquare}) and Figures 4Up and 5Up (CHF cells, {circ}). A and B, 9AC-sensitive current at –80 mV (A) and 9AC-induced cell swelling (B) plotted as functions of relative cell volume before adding 9AC (volumes normalized to that in 1T 9AC-free solution). Maximum responses to 9AC were observed at relative cell volumes of 1.073±0.011 (0.9T) and 1.254±0.012 (0.7T) in CHF and normal cells, respectively. C, Approximately linear relationship between 9AC-induced block of current and 9AC-induced increase in cell volume.

Myocytes were harvested from both the left and right ventricles of CHF and normal dogs. Table 2Down shows that the source of the cells had no significant effect on 9AC-sensitive current or 9AC-induced cell swelling. Consequently, data from right- and left-ventricular myocytes have been combined.


View this table:
[in this window]
[in a new window]
 
Table 2. 9AC-Induced Changes in Ionic Current and Cell Volume in Right and Left Ventricular Myocytes

Dose Dependence of Effect of 9AC on Myocyte Volume and Current
Inhibition of ICl,swell by 9AC and the ensuing cell swelling were dose dependent in both normal and CHF cells. Normal cells first were swollen in NMDG-0.6T solution to activate ICl,swell in the absence of cation SAC current, ICir,swell, and then were exposed for 5-minute periods to successively higher doses of 9AC (0.01 to 1 mmol/L) in 0.6T solution. As the 9AC concentration was increased, the magnitude of the blocked current (Figure 7AUp) and cell volume (Figure 7BUp) both increased significantly in a graded fashion. The dose dependence of the effects of 9AC are compared in Figure 7CUp with the responses at 1 mmol/L scaled to an equal height. This emphasizes that block of current and cell swelling were proportional at different concentrations of 9AC. Analogous experiments were conducted on CHF myocytes in NMDG-1T solution. 9AC-sensitive currents (Figure 7DUp) and 9AC-induced cell swelling (Figure 7EUp) are illustrated. Stepwise increases in 9AC concentration elicited a proportional block of current at –80 mV and cell swelling in CHF cells (Figure 7FUp), as it did in normal cells (Figure 7CUp).

Figures 7AUp and 7DUp also provide information on the efficacy of 9AC as a blocker of ICl,swell. The magnitude of ICl,swell can be estimated as the current elicited on switching from NMDG-1T to NMDG-0.6T solution for normal cells (Figure 7AUp, curve b-a) and from NMDG-1T to NMDG-1.5T solution for CHF cells (Figure 7DUp, curve a-b). The maximum dose of 9AC used, 1 mmol/L, blocked 93±1% and 89±1% of ICl,swell at –80 mV in normal (Figure 7AUp, curve b-e) and CHF (Figure 7DUp, curve a-e) cells, respectively.

Ionic Basis of 9AC-Sensitive Current and Volume Changes
Experiments in NMDG solutions (Figure 8Down) indicated that Na+ and K+ were not required to elicit a 9AC-sensitive current or 9AC-induced cell swelling. If 9AC is acting as a Cl channel blocker,1 18 replacement of Cl with a larger, poorly permeant anion should markedly attenuate the effects of 9AC effect on membrane current and cell volume. To test this prediction, methanesulfonate was substituted for all Cl in the bath, and all but 5 mmol/L Cl in the pipette was replaced with aspartate. Replacement of Cl essentially abolished the effect of 9AC on membrane current (Figure 8ADown and 8CDown) and cell volume (Figure 8BDown and 8DDown) in normal cells in 0.6T solution and CHF cells in 1T solution.



View larger version (29K):
[in this window]
[in a new window]
 
Figure 8. 9AC-sensitive current is anion dependent in normal (A and B, n=4) and CHF (C and D, n=4) myocytes. Cl was replaced with methanesulfonate in the bath and was reduced to 5 mmol/L in the pipette by replacement with aspartate. The effect of 9AC (1 mmol/L) was studied in 1T and 0.6T solution in normal myocytes and in 1T and 1.5T solution for CHF myocytes. After replacing Cl, the 9AC-sensitive current (A and C) and 9AC-induced cell swelling (B and D) were negligible in both normal and CHF cells. Times (a through d) of recording of I-V relationships are indicated in B and D.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
Previously we found that a swelling-activated, Gd3+-sensitive cation current, ICir,swell, was persistently activated in a canine model of CHF.22 The present results show that a swelling-activated anion current, ICl,swell, also was persistently activated under isosmotic conditions in hypertrophic ventricular myocytes isolated from dogs with tachycardia-induced cardiomyopathy. Whereas osmotic swelling of CHF cells only modestly increased ICl,swell, graded osmotic shrinkage caused graded inhibition of the current. Full inhibition at –80 mV was achieved by shrinking myocytes to a relative volume of 0.821±0.008 in 1.4T solution. In contrast, ICl,swell was absent in cells isolated from normal dogs bathed in isosmotic solution, but it was activated in a graded fashion with graded osmotic swelling in 0.9T to 0.6T solutions at cell volumes ranging from 1.072±0.008 to 1.311±0.014. With full activation, current density was {approx}40% greater in CHF myocytes than in normal myocytes. The currents recorded in both normal and CHF cells reversed at the same potential and were blocked in a dose-dependent manner by 9AC, a blocker of ICl,swell. Concurrent with block of ICl,swell, 9AC caused cell volume to increase. The 9AC-induced cell swelling was proportional to the magnitude of ICl,swell and the concentration of 9AC. Thus, swelling-activated anion channels may modulate cardiac electrical activity and cell volume in CHF.

Characteristics of ICl,swell
The currents described here in both normal and CHF cells (1) were dependent on cell volume, (2) were dependent on Cl with Erev near ECl, (3) were insensitive to replacement of bath Na+ and K+ by NMDG, (4) exhibited outward rectification under asymmetric conditions, and (5) were attenuated by 9AC. These features match those of ICl,swell, described by Tseng1 in normal canine ventricular cells and Sorota2 in normal canine atrial cells. ICl,swell is found in normal cells from a number of species31 including humans.6 7 32 33 Sorota18 found that 9AC blocked by 50%, whereas niflumic acid completely blocked ICl,swell at all voltages. Block by 4,4'-dinitrostilbene-2,2'-disulfonic acid (DNDS) was voltage dependent, with only partial block at negative voltages and complete block at membrane voltages >0 mV.18 Preliminary data confirm that niflumic acid completely blocks ICl,swell (H.F.C. and C.M.B., unpublished data, 1998), but the present study found that 9AC blocks >90% of ICl,swell (see Figure 7Up) in canine myocytes at all membrane voltages. The reasons for the discrepancy between the present results and those of Sorota18 on the efficacy of 9AC are unclear but may include methodological differences or subtle differences between canine atrial and ventricular myocytes. Sorota2 was unable to elicit ICl,swell in canine ventricular myocytes using the nystatin-perforated-patch method but did observe this current in canine atrial myocytes under the same conditions.

We found that substitution of methanesulfonate in the bath for Cl caused almost complete inhibition of ICl,swell in both CHF and normal cells (see Figure 8Up). Others have reported that the permeability ratio PCl/Pmethanesulfonate is 0.25 to 0.35 in cardiac myocytes.5 7 34 The pipette Cl concentration ([Cl]I) in these studies was on the order of 40 mmol/L, considerably higher than the 6 mmol/L used in the present Cl substitution experiments. It is possible that [Cl]i modulates the selectivity of ICl,swell. Also, other studies typically use a ruptured rather than a perforated-patch voltage clamp.

A number of molecular candidates for ICl,swell have been proposed, including ClC-2,8 PICln,9 10 P-glycoprotein,11 12 phospholemman,13 and ClC-3.14 Presently, the most likely candidate for ICl,swell appears to be ClC-3, a member of the Cl channel superfamily (for review, see References 35 and 3635 36 ). This channel protein has been isolated from guinea pig ventricle,14 as well as from other tissues and species. Key characteristics of the ClC-3 channel include (1) outward rectification, (2) anion selectivity with I>Cl, and (3) activation and inactivation of current by protein kinase C (PKC) inhibition and stimulation, respectively.14 37 38 We recently demonstrated that ICl,swell in normal rabbit39 and canine40 ventricular myocytes shares these 3 properties and thus may be caused by ClC-3.

ICl,swell in CHF
This study demonstrates that a Cl current is active under isosmotic conditions in canine CHF myocytes. Bénitah et al41 recently reported that a 9AC-sensitive Cl current was present in rat ventricular myocytes obtained from a pressure-overload model (aortic constriction) of hypertrophy but not in normal cells. The authors did not test whether the Cl current they observed in hypertrophied rat myocytes was sensitive to cell volume and did not identify it as ICl,swell. It is likely, however, that the current found by Bénitah et al41 was the same as that identified here and shown to be volume sensitive. Moreover, preliminary data from CHF myocytes from both the present canine rapid pacing model (H.F.C. and C.M.B., unpublished data, 1998) and a rabbit aortic regurgitation model39 strongly suggest that persistently activated ICl,swell arises from ClC-3. ICl,swell recorded in 1T in myocytes from both CHF models exhibits I>Cl selectivity and is inhibited by activation of PKC by phorbol-12,13-dibutyrate. Taken together, these data suggest that persistent activation of ICl,swell during the myocardial remodeling associated with hypertrophy and failure is not peculiar to a particular model of CHF or experimental species but rather is a common feature of several models in several species.

In both the dog and rabbit, ICl,swell current density was 40% greater in CHF than in normal cells. Presently, it is not known whether increased expression of ICl,swell channels, increased probability of channel opening, or an increased unitary conductance in CHF cells can explain these differences. Others have described an increase in ICl,swell current density in cardiac hypertrophy41 and cell proliferation.42

As previously mentioned, inactivation of PKC appears to stimulate ICl,swell in heart.38 39 CHF induced in the rabbit by left-ventricular pressure and volume overload causes a reduction in the expression of a number of PKC isoforms.43 Heart failure in the rabbit induced by pressure overload (aortic constriction) also causes a decrease in the particulate PKC fraction,44 which is in contrast to an overall increase in PKC activity and content in a similar rat model.45 46 Thus, a reduction of particulate PKC activity in CHF cells under isosmotic conditions or in normal cells under hyposmotic conditions could underlie activation of ICl,swell. Another possible mediator of ICl,swell is tyrosine kinase. Sorota47 found that genistein, an inhibitor of tyrosine kinase, prevented activation of ICl,swell by hyposmotic bath solution in canine atrial myocytes. Further, both cell swelling48 and stretch49 rapidly initiate tyrosine kinase-dependent activation of immediate-early genes such as c-fos in rat cardiac myocytes. Given that tyrosine kinases mediate angiotensin II-stimulated cell responses to hypertension, ischemic insult, and CHF,50 a tyrosine kinase–dependent activation of ICl,swell in CHF is possible, although not proven at the present time.

Pathophysiology
At positive membrane potentials, ICl,swell is outwardly directed and presumably contributes to membrane repolarization in phases 2 and 3 of the action potential and will thus shorten the action potential. Vandenberg et al15 showed that acute swelling of guinea pig ventricular myocytes causes action potential shortening that could be attenuated by the ICl,swell blocker 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS). The cardiac action potential is prolonged in humans with heart failure, cardiac hypertrophy, or ischemic cardiomyopathy.51 52 53 Activation of ICl,swell by CHF (as demonstrated in this study) or by cardiac hypertrophy41 may thus serve to limit the extent of action potential prolongation in various pathological states. Indeed, Bénitah et al41 showed that action potentials of hypertrophied rat ventricular myocytes prolonged when treated with the ICl,swell blocker 9AC. At negative membrane potentials, ICl,swell is inwardly directed and when activated should cause membrane depolarization. Cell swelling causes membrane depolarization in both canine atrial myocytes16 and in guinea pig ventricular myocytes.15 This membrane depolarization was blocked by ICl,swell blockers such as niflumic acid and DIDS.

In summary, ICl,swell was shown to be chronically activated in canine tachycardia-induced cardiomyopathy, and it appears likely that the same current is chronically activated in other forms of CHF and cardiac hypertrophy. Although the pathophysiological role of ICl,swell presently is uncertain, it may contribute to ventricular dysrhythmias associated with hypertrophy and failure.


*    Acknowledgments
 
This study was supported by National Heart, Lung, and Blood Institute grants HL-02798 (H.F.C.) and HL-46764 (C.M.B.) and a Merit Review Award from the Department of Veterans Affairs (B.S.S.).

Received September 29, 1998; accepted November 5, 1998.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Tseng G-N. Cell swelling increases membrane conductance of canine cardiac cells: evidence for a volume-sensitive Cl channel. Am J Physiol. 1992;262:C1056–C1067.[Abstract/Free Full Text]

2. Sorota S. Swelling-induced chloride-sensitive current in dog atrial cells revealed by whole cell patch clamp method. Circ Res. 1992;70:679–687.[Abstract/Free Full Text]

3. Hagiwara N, Masuda H, Shoda M, Irisawa H. Stretch-activated anion currents of rabbit cardiac myocytes. J Physiol (Lond). 1992;456:285–302.[Abstract/Free Full Text]

4. Coulombe A, Coraboeuf E. Large-conductance chloride channels of new-born rat cardiac myocytes are activated by hypotonic media. Pflügers Arch. 1992;422:143–150.

5. Zhang J, Rasmusson RL, Hall SK, Lieberman M. A chloride current associated with swelling of cultured chick heart cells. J Physiol (Lond). 1993;472:801–820.[Abstract/Free Full Text]

6. Sakai R, Hagiwara N, Kasanuki H, Hosoda S. Chloride conductance in human atrial cells. J Mol Cell Cardiol. 1995;27:2403–2408.[Medline] [Order article via Infotrieve]

7. Li GR, Feng J, Wang Z, Nattel S. Transmembrane chloride currents in human atrial myocytes. Am J Physiol. 1996;270:C500–C507.[Abstract/Free Full Text]

8. Grunder S, Thiemann A, Pusch M, Jentsch TJ. Regions involved in the opening of ClC-2 chloride channel by voltage and volume. Nature. 1992;360:759–762.[Medline] [Order article via Infotrieve]

9. Paulmichl M, Li Y, Wickman K, Ackerman M, Peralta E, Clapham D. New mammalian chloride channel identified by expression cloning. Nature. 1992;356:238–241.[Medline] [Order article via Infotrieve]

10. Krapivinsky GB, Ackerman MJ, Gordon EA, Krapivinsky LD, Clapham DE. Molecular characterization of a swelling-induced chloride conductance regulatory protein, PICln. Cell. 1994;76:439–448.[Medline] [Order article via Infotrieve]

11. Gill DR, Hyde SC, Kiggins DF, Valverde MA, Minteng GM, Sepulveda FV. Separation of drug transport and chloride channel functions of human multidrug resistance P-glycoprotein. Cell. 1992;71:23–32.[Medline] [Order article via Infotrieve]

12. Valverde MA, Diaz M, Sepulveda M, Gill DG, Hyde SC, Higgins CF. Volume regulated chloride channels are associated with the human multidrug-resistance P-glycoprotein. Nature. 1992;355:830–833.[Medline] [Order article via Infotrieve]

13. Moorman JR, Palmer CJ, John JD, Durieux ME, Jones LR. Phospholemman expression induces a hyperpolarization-activated chloride current in Xenopus oocytes. J Biol Chem. 1992;267:14551–14554.[Abstract/Free Full Text]

14. Duan DD, Cowley S, Hume JR, Horowitz B. Molecular identification of a volume-regulated chloride channel. Nature. 1997;390:417–421.[Medline] [Order article via Infotrieve]

15. Vandenberg JI, Bett GC, Powell T. Contribution of a swelling-activated chloride current to changes in the cardiac action potential. Am J Physiol. 1997;273:C541–C547.[Abstract/Free Full Text]

16. Du XY, Sorota S. Cardiac swelling-induced chloride current depolarizes canine atrial myocytes. Am J Physiol. 1997;272:H1904–H1916.[Abstract/Free Full Text]

17. Suleymanian MA, Clemo HF, Cohen NM, Baumgarten CM. Stretch-activated channel blockers modulate cell volume in cardiac ventricular myocytes. J Mol Cell Cardiol. 1995;27:721–728.[Medline] [Order article via Infotrieve]

18. Sorota S. Pharmacologic properties of the swelling-induced chloride current of dog atrial myocytes. J Cardiovasc Electrophysiol. 1994;5:1006–1016.[Medline] [Order article via Infotrieve]

19. Sadoshima J, Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol. 1997;59:551–571.[Medline] [Order article via Infotrieve]

20. Packer M. New concepts in the pathophysiology of heart failure: beneficial and deleterious interaction of endogenous haemodynamic and neurohormonal mechanisms. J Intern Med. 1996;239:327–333.[Medline] [Order article via Infotrieve]

21. Clemo HF, Baumgarten CM. Swelling-activated Gd3+-sensitive current and cell volume regulation in rabbit ventricular myocytes. J Gen Physiol. 1997;110:297–312.[Abstract/Free Full Text]

22. Clemo HF, Stambler BS, Baumgarten CM. Persistent activation of a swelling-activated cation current in ventricular myocytes from dogs with tachycardia-induced congestive heart failure. Circ Res. 1998;83:147–157.[Abstract/Free Full Text]

23. Iannini JP, Spinale FG. The identification of contributory mechanism for the development and progression of congestive heart failure in animal models. J Heart Lung Transplant. 1996;15:1138–1150.[Medline] [Order article via Infotrieve]

24. Morgan JP. Cellular physiology of myocyte contraction. In: Poole-Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coats AJS, eds. Heart Failure: Scientific Principles and Clinical Practice. New York, NY: Churchill Livingstone; 1997:1–11.

25. Weber KT. Cardiac interstitium. In: Poole-Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coats AJS, eds. Heart Failure: Scientific Principles and Clinical Practice. New York, NY: Churchill Livingstone; 1997:13–31.

26. Swynghedauw B. Biologic determinants of myocardial function. In: Poole-Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coats AJS, eds. Heart Failure: Scientific Principles and Clinical Practice. New York, NY: Churchill Livingstone; 1997:33–44.

27. Francis GS. Vasoactive hormone systems. In: Poole-Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coats AJS, eds. Heart Failure: Scientific Principles and Clinical Practice. New York, NY: Churchill Livingstone; 1997:215–234.

28. Clemo HF, Baumgarten CM. Atrial natriuretic factor decreases cell volume of rabbit atrial and ventricular myocytes. Am J Physiol. 1991;260:C681–C690.[Abstract/Free Full Text]

29. Clemo, HF, Feher JJ, Baumgarten CM. Modulation of rabbit ventricular cell volume and Na+/K+/2Cl cotransport by cGMP and atrial natriuretic factor. J Gen Physiol. 1992;100:89–114.[Abstract/Free Full Text]

30. Drewnowska K, Baumgarten CM. Regulation of cellular volume in rabbit ventricular myocytes: bumetanide, chlorothiazide, and ouabain. Am J Physiol. 1991;260:C122–C131.[Abstract/Free Full Text]

31. Nilius B, Eggermont J, Voets T, Buyse G, Manolopoulos V, Droogmans G. Properties of volume-regulated anion channels in mammalian cells. Prog Biophys Mol Biol. 1997;68:69–119.[Medline] [Order article via Infotrieve]

32. Oz MC, Sorota S. Forskolin stimulates swelling-induced chloride current, not cardiac cystic fibrosis transmembrane-conductance regulator current, in human cardiac myocytes. Circ Res. 1995;76:1063–1070.[Abstract/Free Full Text]

33. Sato R, Koumi S-I. Characterization of the stretch-activated chloride channel in isolated human atrial myocytes. J Membr Biol. 1998;163:67–76.[Medline] [Order article via Infotrieve]

34. Leem CH, Ho W-K, Earm YE. The effect of taurine on the activation osmolality of the osmosensitive current in single ventricular myocytes of rabbits. Exp Physiol. 1996;81:189–202.[Abstract]

35. Jentsch TJ, Günther W. Chloride channels: an emerging molecular picture. Bioessays. 1997;19:119–126.

36. Clapham DE. The list of potential volume-sensitive chloride currents continues to swell (and shrink). J Gen Physiol. 1998;111:623–624.[Free Full Text]

37. Kawasaki M, Uchida S, Monkasva T, Miyawaki A, Mikoshiba K, Marumo F, Sasaki S. Cloning and expression of a protein kinase C-regulated chloride channel abundantly expressed in rat brain neuronal cells. Neuron. 1994;12:597–604.[Medline] [Order article via Infotrieve]

38. Duan D, Fermini B, Nattel S. {alpha}-Adrenergic control of volume-regulated Cl currents in rabbit atrial myocytes. Circ Res. 1995;77:373–393.

39. Clemo HF, Baumgarten CM. Protein kinase C activation blocks ICl,swell and causes myocyte swelling in a rabbit congestive heart failure model. Circulation. 1998;98(suppl I):I-695. Abstract.

40. Clemo HF, Danetz JS, Baumgarten CM. Does ClC-3 modulate cardiac cell volume? Biophys J. 1999;76:A203. Abstract.

41. Bénitah, J-P, Gómez AM, Delgado C, Lorente P, Lederer WJ. A chloride current component induced by hypertrophy in rat ventricular myocytes. Am J Physiol. 1997;272:H2500–H2506.[Abstract/Free Full Text]

42. Voets T, Wei L, De Smet P, Van Driessche W, Eggermont J, Droogmans G, Nilius B. Downregulation of volume-activated Cl currents during muscle differentiation. Am J Physiol. 1997;272:C667–C674.[Abstract/Free Full Text]

43. Rouet-Benzineb P, Mohammadi K, Pérennec J, Poyard M, El Houda Bouanani N, Crozatier B. Protein kinase C isoform expression in normal and failing rabbit hearts. Circ Res. 1996;79:153–161.[Abstract/Free Full Text]

44. Mohammadi K, Rouet-Benzineb P, Laplace M, Crozatier B. Protein kinase C activity and expression in rabbit left ventricular hypertrophy. J Mol Cell Cardiol. 1997;29:1687–1694.[Medline] [Order article via Infotrieve]

45. Kwiatkowska-Patzer B, Domanska-Janik K. Increased 19 kDa protein phosphorylation and protein kinase C in pressure-overload cardiac hypertrophy. Basic Res Cardiol. 1991;86:402–409.[Medline] [Order article via Infotrieve]

46. Gu X, Bishop SP. Increased protein kinase C and isozyme redistribution in pressure-overload cardiac hypertrophy in the rat. Circ Res. 1994;75:926–931.[Abstract/Free Full Text]

47. Sorota S. Tyrosine protein kinase inhibitors prevent activation of cardiac swelling-induced chloride current. Pflügers Arch. 1995;431:178–185.

48. Sadoshima J, Qiu Z, Morgan JP, Izumo S. Tyrosine kinase activation is an immediate and essential step in hypotonic cell swelling-induced ERK activation and c-fos gene expression in cardiac myocytes. EMBO J. 1996;15:5535–5546.[Medline] [Order article via Infotrieve]

49. Sadoshima J, Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 1993;12:1681–1692.[Medline] [Order article via Infotrieve]

50. Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle. Circ Res. 1997;80:607–616.[Abstract/Free Full Text]

51. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 1987;61:70–76.[Abstract/Free Full Text]

52. Beuckelmann DJ, Nabauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation. 1992;85:1046–1055.[Abstract/Free Full Text]

53. Koumi S, Backer CL, Arentzen CE. Characterization of inwardly rectifying K+ channel in human cardiac myocytes: alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy. Circulation. 1995;92:164–174.[Abstract/Free Full Text]

54. Gerdes AM, Kellerman SE, Malec KB, Schocken D. Transverse shape characteristics of cardiac myocytes from rats and humans. Cardioscience. 1994;5:31–36.[Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
J. Physiol.Home page
D. Duan
Phenomics of cardiac chloride channels: the systematic study of chloride channel function in the heart
J. Physiol., May 1, 2009; 587(10): 2163 - 2177.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
W. C De Mello
Intracellular and extracellular renin have opposite effects on the regulation of heart cell volume. Implications for myocardial ischaemia
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2008; 9(2): 112 - 118.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
S. J. Kim and Y. E. Earm
Journeying down the long and winding road: the whole picture of volume-activated Cl- channel activation in cardiac myocytes
Cardiovasc Res, January 1, 2008; 77(1): 6 - 7.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
Z. Ren, F. J. Raucci Jr., D. M. Browe, and C. M. Baumgarten
Regulation of swelling-activated Cl- current by angiotensin II signalling and NADPH oxidase in rabbit ventricle
Cardiovasc Res, January 1, 2008; 77(1): 73 - 80.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. O. Verkerk, A. C.G. van Ginneken, G. Berecki, H. M. den Ruijter, C. A. Schumacher, M. W. Veldkamp, A. Baartscheer, S. Casini, T. Opthof, R. Hovenier, et al.
Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials
Cardiovasc Res, June 1, 2006; 70(3): 509 - 520.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
D. M. Browe and C. M. Baumgarten
EGFR Kinase Regulates Volume-sensitive Chloride Current Elicited by Integrin Stretch via PI-3K and NADPH Oxidase in Ventricular Myocytes
J. Gen. Physiol., February 27, 2006; 127(3): 237 - 251.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Ren and C. M. Baumgarten
Antagonistic regulation of swelling-activated Cl- current in rabbit ventricle by Src and EGFR protein tyrosine kinases
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2628 - H2636.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
D. M. Browe and C. M. Baumgarten
Angiotensin II (AT1) Receptors and NADPH Oxidase Regulate Cl- Current Elicited by {beta}1 Integrin Stretch in Rabbit Ventricular Myocytes
J. Gen. Physiol., August 30, 2004; 124(3): 273 - 287.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C.-E. Chiang, H.-N. Luk, and T.-M. Wang
Swelling-activated chloride current is activated in guinea pig cardiomyocytes from endotoxic shock
Cardiovasc Res, April 1, 2004; 62(1): 96 - 104.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
D. M. Browe and C. M. Baumgarten
Stretch of {beta}1 Integrin Activates an Outwardly Rectifying Chloride Current via FAK and Src in Rabbit Ventricular Myocytes
J. Gen. Physiol., November 24, 2003; 122(6): 689 - 702.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. G. Akar, T. H. Everett, R. Ho, J. Craft, D. E. Haines, A. P. Somlyo, and A. V. Somlyo
Intracellular Chloride Accumulation and Subcellular Elemental Distribution During Atrial Fibrillation
Circulation, April 8, 2003; 107(13): 1810 - 1815.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. C. Nicolosi, G. West, J. G. Markley, B. Logan, and G. N. Olinger
Gadolinium attenuates regional stunning in the canine heart in vivo
J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 57 - 62.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. M.G.J van Borren, A. O Verkerk, S. K Vanharanta, A. Baartscheer, R. Coronel, and J. H Ravesloot
Reduced swelling-activated Cl- current densities in hypertrophied ventricular myocytes of rabbits with heart failure
Cardiovasc Res, March 1, 2002; 53(4): 869 - 878.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. O. Verkerk, M. W. Veldkamp, A. Baartscheer, C. A. Schumacher, C. Klopping, A. C.G. van Ginneken, and J. H. Ravesloot
Ionic Mechanism of Delayed Afterdepolarizations in Ventricular Cells Isolated From Human End-Stage Failing Hearts
Circulation, November 27, 2001; 104(22): 2728 - 2733.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. D. Harding, V. Piacentino III, J. P. Gaughan, S. R. Houser, and K. B. Margulies
Electrophysiological Alterations After Mechanical Circulatory Support in Patients With Advanced Cardiac Failure
Circulation, September 11, 2001; 104(11): 1241 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
S. Kaab and M. Nabauer
Diversity of ion channel expression in health and disease
Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K31 - K40.
[Abstract] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Y. Estevez, T. Bond, and K. Strange
Regulation of ICl,swell in neuroblastoma cells by G protein signaling pathways
Am J Physiol Cell Physiol, July 1, 2001; 281(1): C89 - C98.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. C. Nicolosi, C. S. Kwok, S. J. Contney, G. N. Olinger, and Z. J. Bosnjak
Gadolinium prevents stretch-mediated contractile dysfunction in isolated papillary muscles
Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1122 - H1128.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J.-Q. He, M. W Conklin, J. D Foell, M. R Wolff, R. A Haworth, R. Coronado, and T. J Kamp
Reduction in density of transverse tubules and L-type Ca2+ channels in canine tachycardia-induced heart failure
Cardiovasc Res, February 1, 2001; 49(2): 298 - 307.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. S. Danetz, R. D. Davies, H. F. Clemo, and C. M. Baumgarten
RABBIT VENTRICULAR MYOCYTE VOLUME CHANGES AS A DIRECT RESULT OF CRYSTALLOID CARDIOPLEGIA IN CONGESTIVE HEART FAILURE INDUCED BY AORTIC REGURGITATION
J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 826 - 833.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Nagasaki, L. Ye, D. Duan, B. Horowitz, and J. R Hume
Intracellular cyclic AMP inhibits native and recombinant volume-regulated chloride channels from mammalian heart
J. Physiol., March 15, 2000; 523(3): 705 - 717.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. R. Hume, D. Duan, M. L. Collier, J. Yamazaki, and B. Horowitz
Anion Transport in Heart
Physiol Rev, January 1, 2000; 80(1): 31 - 81.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. S. Danetz, H. F. Clemo, R. D. Davies, R. P. Embrey, R. J. Damiano Jr, and C. M. Baumgarten
AGE-RELATED EFFECTS OF ST THOMAS’ HOSPITAL CARDIOPLEGIC SOLUTION ON ISOLATED CARDIOMYOCYTE CELL VOLUME
J. Thorac. Cardiovasc. Surg., September 1, 1999; 118(3): 467 - 476.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G.-R. Li, M. Zhang, L. S. Satin, and C. M. Baumgarten
Biphasic effects of cell volume on excitation-contraction coupling in rabbit ventricular myocytes
Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1270 - H1277.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clemo, H. F.
Right arrow Articles by Baumgarten, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clemo, H. F.
Right arrow Articles by Baumgarten, C. M.
Related Collections
Right arrow Animal models of human disease
Right arrow Arrythmias-basic studies
Right arrow Heart failure - basic studies